Latest Ratings for ESS Date Firm Action From To Feb 2022 Mizuho Maintains Buy Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Keybanc Maintains Overweight View More Analyst Ratings for ESS View the Latest Analyst Ratings read more
Latest Ratings for CRK Date Firm Action From To Aug 2021 Mizuho Maintains Buy Jul 2021 Mizuho Maintains Buy Mar 2021 Piper Sandler Downgrades Overweight Neutral View More Analyst Ratings for CRK View the Latest Analyst Ratings read more
A Benzinga reader poll shows high confidence that the SPDR S&P 500 ETF Trust will hit new all-time highs again in 2025. But by how much? read more
Merck’s Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE-689 trial. read more
Private equity firms circle Bojangles and Papa John’s; Meta buys into Scale AI; Advent, Bain, and Disney also make bold moves. read more
Coinbase, now in the S&P 500, reflects mainstream acceptance, but tariff-induced market turbulence threatens its momentum. read more